Buddleoside-Rich Chrysanthemum indicum L. Extract has a Beneficial Effect on Metabolic Hypertensive Rats by Inhibiting the Enteric-Origin LPS/TLR4 Pathway

As the number of patients with metabolic hypertension (MH) is increasing, there is an essential require for global measures to prevent and treat MH. Flavonoids such as buddleoside (BUD) from Chrysanthemum indicum L. are the main pharmacological components of cardiovascular activities. Previous studi...

Full description

Bibliographic Details
Main Authors: Ya-Jun Wang, Jie Su, Jing-Jing Yu, Mei-Qiu Yan, Meng-Lin Shi, Qi-Di Huang, Bo Li, Wen-Yan Wu, Rong-Shuang Xia, Si-Fan Li, Su-Hong Chen, Gui-Yuan Lv
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.755140/full
id doaj-0766d90e474f42b7b3e3285c7b240236
record_format Article
spelling doaj-0766d90e474f42b7b3e3285c7b2402362021-10-08T10:50:40ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-10-011210.3389/fphar.2021.755140755140Buddleoside-Rich Chrysanthemum indicum L. Extract has a Beneficial Effect on Metabolic Hypertensive Rats by Inhibiting the Enteric-Origin LPS/TLR4 PathwayYa-Jun Wang0Jie Su1Jing-Jing Yu2Mei-Qiu Yan3Meng-Lin Shi4Qi-Di Huang5Bo Li6Wen-Yan Wu7Rong-Shuang Xia8Si-Fan Li9Su-Hong Chen10Gui-Yuan Lv11School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, ChinaSchool of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, ChinaSchool of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, ChinaSchool of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, ChinaSchool of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, ChinaSchool of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, ChinaCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, ChinaSchool of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, ChinaSchool of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, ChinaSchool of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, ChinaCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, ChinaSchool of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, ChinaAs the number of patients with metabolic hypertension (MH) is increasing, there is an essential require for global measures to prevent and treat MH. Flavonoids such as buddleoside (BUD) from Chrysanthemum indicum L. are the main pharmacological components of cardiovascular activities. Previous studies have suggested that the buddleoside-rich Chrysanthemum indicum L. extract (BUDE) can reduce blood pressure in spontaneously hypertensive rats (SHR). However, its effect on MH and how it works remains to be researched. In this study, it was observed that BUDE could lower blood pressure, improve dyslipidemia, and decrease the level of plasma LPS in MH rats. Moreover, BUDE improved intestinal flora and increased the expression of occludin and claudin-1 in the colon, and improved the pathological injury of the colon. Western bolt and qRT-PCR experiments showed that BUDE could down-regulate TLR4 and MyD88 protein and mRNA expression and inhibit phosphorylation of IKKβ, IκBα and NF-κB p65 in vessels of MH rats. These results showed that BUDE could regulate intestinal flora, improve intestinal barrier function, reduce the production and penetration of LPS, thereby inhibiting the vascular TLR4/MyD88 pathway, improving vascular endothelial function, and ultimately lowering blood pressure in MH rats. This study provides a new mechanism of BUDE against MH by inhibiting the enteric-origin LPS/TLR4 pathway.https://www.frontiersin.org/articles/10.3389/fphar.2021.755140/fullmetabolic hypertensivebuddleosidelipopolysaccharideintestinal floraenteric-origin LPS/TLR4
collection DOAJ
language English
format Article
sources DOAJ
author Ya-Jun Wang
Jie Su
Jing-Jing Yu
Mei-Qiu Yan
Meng-Lin Shi
Qi-Di Huang
Bo Li
Wen-Yan Wu
Rong-Shuang Xia
Si-Fan Li
Su-Hong Chen
Gui-Yuan Lv
spellingShingle Ya-Jun Wang
Jie Su
Jing-Jing Yu
Mei-Qiu Yan
Meng-Lin Shi
Qi-Di Huang
Bo Li
Wen-Yan Wu
Rong-Shuang Xia
Si-Fan Li
Su-Hong Chen
Gui-Yuan Lv
Buddleoside-Rich Chrysanthemum indicum L. Extract has a Beneficial Effect on Metabolic Hypertensive Rats by Inhibiting the Enteric-Origin LPS/TLR4 Pathway
Frontiers in Pharmacology
metabolic hypertensive
buddleoside
lipopolysaccharide
intestinal flora
enteric-origin LPS/TLR4
author_facet Ya-Jun Wang
Jie Su
Jing-Jing Yu
Mei-Qiu Yan
Meng-Lin Shi
Qi-Di Huang
Bo Li
Wen-Yan Wu
Rong-Shuang Xia
Si-Fan Li
Su-Hong Chen
Gui-Yuan Lv
author_sort Ya-Jun Wang
title Buddleoside-Rich Chrysanthemum indicum L. Extract has a Beneficial Effect on Metabolic Hypertensive Rats by Inhibiting the Enteric-Origin LPS/TLR4 Pathway
title_short Buddleoside-Rich Chrysanthemum indicum L. Extract has a Beneficial Effect on Metabolic Hypertensive Rats by Inhibiting the Enteric-Origin LPS/TLR4 Pathway
title_full Buddleoside-Rich Chrysanthemum indicum L. Extract has a Beneficial Effect on Metabolic Hypertensive Rats by Inhibiting the Enteric-Origin LPS/TLR4 Pathway
title_fullStr Buddleoside-Rich Chrysanthemum indicum L. Extract has a Beneficial Effect on Metabolic Hypertensive Rats by Inhibiting the Enteric-Origin LPS/TLR4 Pathway
title_full_unstemmed Buddleoside-Rich Chrysanthemum indicum L. Extract has a Beneficial Effect on Metabolic Hypertensive Rats by Inhibiting the Enteric-Origin LPS/TLR4 Pathway
title_sort buddleoside-rich chrysanthemum indicum l. extract has a beneficial effect on metabolic hypertensive rats by inhibiting the enteric-origin lps/tlr4 pathway
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2021-10-01
description As the number of patients with metabolic hypertension (MH) is increasing, there is an essential require for global measures to prevent and treat MH. Flavonoids such as buddleoside (BUD) from Chrysanthemum indicum L. are the main pharmacological components of cardiovascular activities. Previous studies have suggested that the buddleoside-rich Chrysanthemum indicum L. extract (BUDE) can reduce blood pressure in spontaneously hypertensive rats (SHR). However, its effect on MH and how it works remains to be researched. In this study, it was observed that BUDE could lower blood pressure, improve dyslipidemia, and decrease the level of plasma LPS in MH rats. Moreover, BUDE improved intestinal flora and increased the expression of occludin and claudin-1 in the colon, and improved the pathological injury of the colon. Western bolt and qRT-PCR experiments showed that BUDE could down-regulate TLR4 and MyD88 protein and mRNA expression and inhibit phosphorylation of IKKβ, IκBα and NF-κB p65 in vessels of MH rats. These results showed that BUDE could regulate intestinal flora, improve intestinal barrier function, reduce the production and penetration of LPS, thereby inhibiting the vascular TLR4/MyD88 pathway, improving vascular endothelial function, and ultimately lowering blood pressure in MH rats. This study provides a new mechanism of BUDE against MH by inhibiting the enteric-origin LPS/TLR4 pathway.
topic metabolic hypertensive
buddleoside
lipopolysaccharide
intestinal flora
enteric-origin LPS/TLR4
url https://www.frontiersin.org/articles/10.3389/fphar.2021.755140/full
work_keys_str_mv AT yajunwang buddleosiderichchrysanthemumindicumlextracthasabeneficialeffectonmetabolichypertensiveratsbyinhibitingtheentericoriginlpstlr4pathway
AT jiesu buddleosiderichchrysanthemumindicumlextracthasabeneficialeffectonmetabolichypertensiveratsbyinhibitingtheentericoriginlpstlr4pathway
AT jingjingyu buddleosiderichchrysanthemumindicumlextracthasabeneficialeffectonmetabolichypertensiveratsbyinhibitingtheentericoriginlpstlr4pathway
AT meiqiuyan buddleosiderichchrysanthemumindicumlextracthasabeneficialeffectonmetabolichypertensiveratsbyinhibitingtheentericoriginlpstlr4pathway
AT menglinshi buddleosiderichchrysanthemumindicumlextracthasabeneficialeffectonmetabolichypertensiveratsbyinhibitingtheentericoriginlpstlr4pathway
AT qidihuang buddleosiderichchrysanthemumindicumlextracthasabeneficialeffectonmetabolichypertensiveratsbyinhibitingtheentericoriginlpstlr4pathway
AT boli buddleosiderichchrysanthemumindicumlextracthasabeneficialeffectonmetabolichypertensiveratsbyinhibitingtheentericoriginlpstlr4pathway
AT wenyanwu buddleosiderichchrysanthemumindicumlextracthasabeneficialeffectonmetabolichypertensiveratsbyinhibitingtheentericoriginlpstlr4pathway
AT rongshuangxia buddleosiderichchrysanthemumindicumlextracthasabeneficialeffectonmetabolichypertensiveratsbyinhibitingtheentericoriginlpstlr4pathway
AT sifanli buddleosiderichchrysanthemumindicumlextracthasabeneficialeffectonmetabolichypertensiveratsbyinhibitingtheentericoriginlpstlr4pathway
AT suhongchen buddleosiderichchrysanthemumindicumlextracthasabeneficialeffectonmetabolichypertensiveratsbyinhibitingtheentericoriginlpstlr4pathway
AT guiyuanlv buddleosiderichchrysanthemumindicumlextracthasabeneficialeffectonmetabolichypertensiveratsbyinhibitingtheentericoriginlpstlr4pathway
_version_ 1716838474024222720